RK
Rudolf Kwan
EVP, Chief Medical Officer

Rudolf Kwan insider trades: Athenex (ATNX) stock purchases

EVP, Chief Medical Officer, Athenex Last trade Nov 16, 2021 49 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2018
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Rudolf reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 16, 2021ATNX↑ Buy$8K
Jun 22, 2020ATNX↑ Buy$13K
Mar 18, 2020ATNX↑ Buy$24K
Mar 12, 2020ATNX↑ Buy$16K
Mar 9, 2020ATNX↑ Buy$20K
Aug 15, 2019ATNX↑ Buy$15K
Nov 19, 2018ATNX↑ Buy$12K
Nov 14, 2018ATNX↑ Buy$52K
Nov 14, 2018ATNX↑ Buy$105K
Mar 26, 2018ATNX↑ Buy$29K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Rudolf Kwan's insider trades

Rudolf Kwan is EVP, Chief Medical Officer at Athenex (ATNX). Since Mar 26, 2018, Rudolf has reported 10 open-market purchases worth $293K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (38 filings), option exercises (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.